Meanwhile, p53 mutation can prevent the proper folding of the p53 protein or directly disrupt its DNA-binding ability, and thus the tumor may acquire new oncogenic properties such as drug-resistance (Raimundo et al., 2020). Here, TP53 is linked to neoplasm.